MedPath

Short Message System (SMS) for Caregivers of Suicidal Patients to Prevent Recidivism of Suicide Attempts

Not Applicable
Completed
Conditions
Prevention of the Suicide
Interventions
Device: SMS
Registration Number
NCT03069560
Lead Sponsor
University Hospital, Brest
Brief Summary

Assessment of the feasibility of a monitoring device by SMS in which messages are sent by the caregiver after a suicidal act.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
15
Inclusion Criteria
  • Male or female, over 18 years of age and hospitalized;
  • Survivor of a suicide attempt;
  • Giving informed, dated and signed consent;
  • Can be reached by mobile phone. The study is proposed to all adult suicides and to the patient's designated caregiver, meeting the inclusion criteria.
Exclusion Criteria
  • Patient whose clinical condition is incompatible with the formulation of his non-opposition.
  • The patient and his / her caregiver shall not be afforded a protective justice measure.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
SMSSMSThe patients will receive from the caregiver a first SMS 48 hours after their discharge from the hospital then a total of 4 messages : 48 hours, S1, S2, and S4.
Primary Outcome Measures
NameTimeMethod
Measurement of the feasibility of the device by the patient according to a validated questionnaire6 months

The primary endpoint is the measurement of the feasibility of the device by the patient based on a validated questionnaire. This evaluation will take place during the medical interview that will close the study participation.

Secondary Outcome Measures
NameTimeMethod
Qualitative analysis of messages sent to patients during the study.6 months

A qualitative analysis of the messages addressed to the patients during the study will be carried out.

The questionnaire measuring the feasibility for the caregiver of such a device6 months

A questionnaire will be provided to the caregiver to measure the feasibility of such a device

Questionnaires on the acceptability of patients and caregivers in relation to the use of this type of monitoring device6 months

Acceptability questionnaires will be provided to patients and caregivers in relation to the use of this type of monitoring device

Trial Locations

Locations (1)

CHU de Brest

🇫🇷

Brest, France

© Copyright 2025. All Rights Reserved by MedPath